These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A novel mutation in the SCN5A gene is associated with Brugada syndrome. Shin DJ; Kim E; Park SB; Jang WC; Bae Y; Han J; Jang Y; Joung B; Lee MH; Kim SS; Huang H; Chahine M; Yoon SK Life Sci; 2007 Jan; 80(8):716-24. PubMed ID: 17141278 [TBL] [Abstract][Full Text] [Related]
29. SCN5A overlap syndromes: no end to disease complexity? Remme CA; Wilde AA Europace; 2008 Nov; 10(11):1253-5. PubMed ID: 18820249 [No Abstract] [Full Text] [Related]
30. Clinical aspects and physiopathology of Brugada syndrome: review of current concepts. Herbert E; Chahine M Can J Physiol Pharmacol; 2006; 84(8-9):795-802. PubMed ID: 17111025 [TBL] [Abstract][Full Text] [Related]
31. Mutation-specific effects of lidocaine in Brugada syndrome. Clancy CE; Wehrens XH Int J Cardiol; 2007 Oct; 121(3):249-52. PubMed ID: 17761312 [TBL] [Abstract][Full Text] [Related]
32. Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation. Casini S; Tan HL; Bhuiyan ZA; Bezzina CR; Barnett P; Cerbai E; Mugelli A; Wilde AA; Veldkamp MW Cardiovasc Res; 2007 Dec; 76(3):418-29. PubMed ID: 17854786 [TBL] [Abstract][Full Text] [Related]
33. Just another Brugada syndrome mutation? Napolitano C Heart Rhythm; 2007 Jan; 4(1):54-5. PubMed ID: 17198990 [No Abstract] [Full Text] [Related]
34. Making sense in a nonsense reading frame: suppression of cardiac sodium channel dysfunction. Schulze-Bahr E Cardiovasc Res; 2009 Aug; 83(3):423-4. PubMed ID: 19528082 [No Abstract] [Full Text] [Related]
35. Comparison of long-term follow-up of electrocardiographic features in Brugada syndrome between the SCN5A-positive probands and the SCN5A-negative probands. Yokokawa M; Noda T; Okamura H; Satomi K; Suyama K; Kurita T; Aihara N; Kamakura S; Shimizu W Am J Cardiol; 2007 Aug; 100(4):649-55. PubMed ID: 17697823 [TBL] [Abstract][Full Text] [Related]
36. Clinical heterogeneity in sodium channelopathies. What is the meaning of carrying a genetic mutation? Oliva A; Bjerregaard P; Hong K; Evans S; Vernooy K; McCormack J; Brugada J; Brugada P; Pascali VL; Brugada R Cardiology; 2008; 110(2):116-22. PubMed ID: 17971661 [TBL] [Abstract][Full Text] [Related]
37. High-density substrate mapping in Brugada syndrome: combined role of conduction and repolarization heterogeneities in arrhythmogenesis. Lambiase PD; Ahmed AK; Ciaccio EJ; Brugada R; Lizotte E; Chaubey S; Ben-Simon R; Chow AW; Lowe MD; McKenna WJ Circulation; 2009 Jul; 120(2):106-17, 1-4. PubMed ID: 19564561 [TBL] [Abstract][Full Text] [Related]